Objective To evaluate the effects of tolterodine, vamicamide and temiverine
, novel antimuscarinic drugs developed for the treatment of frequency and u
rinary incontinence, on human detrusor smooth muscle.
Materials and methods Specimens of human urinary bladder were obtained from
20 patients who underwent total cystectomy for malignant bladder tumour. U
sing an organ-bath technique, the effects of various drugs on the contracti
ons induced by carbachol, KCl, CaCl2 and electrical field stimulation in th
e detrusor strips were investigated.
Results Carbachol (0.001-10000 mu mol/L) caused concentration-dependent con
tractions in human detrusor smooth muscles. Tolterodine (0.01-10 mu mol/L),
vamicamide (0.01-10 mu mol/L), temiverine (0.01-1 mu mol/L) and atropine (
0.001-1 mu mol/L) caused parallel shifts to the right of the concentration-
response curves to carbachol. All slopes for the regression line of Schild
plots were close to unity, and the rank order of pA(2) values was atro-pine
= tolterodine > vamicamide > temiverine. Tolterodine, vamicamide and atrop
ine did not inhibit the maximum contractile responses to carbachol, while t
emiverine (10 mu mol/L) significantly inhibited the maximum contractions. T
olterodine (0.001-1 mu mol/L) and vamicamide (0.01-10 mu mol/L) did not inh
ibit the KCl- (80 mmol/L) and CaCl2-induced (5 mmol/L) contractions, while
temiverine (0.01-10 mu mol/L) significantly inhibited the contractions. Ele
ctrical field stimulation (2-60 Hz) caused frequency-dependent contractions
in human detrusor smooth muscles, which were significantly inhibited by va
rious drugs. In the presence of 1 mu mol/L atropine, tolterodine and vamica
mide did not inhibit the contractions induced by electrical field stimulati
on at all frequencies, while temiverine (10 mu mol/L) significantly inhibit
ed the contractions.
Conclusion Tolterodine and vamicamide inhibited contractions of human detru
sor smooth muscles only through their antimuscarinic action, while temiveri
ne had both antimuscarinic and calcium-antagonist actions. Furthermore, the
se novel drugs have different efficacies and potencies for inhibiting human
detrusor smooth muscle.